v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid in Capital
Retained Earnings
Unallocated Common Stock of ESOP
Accumulated Other Comprehensive Income (Loss)
Total
Balance at beginning of period at Dec. 31, 2024 $ 260 $ 114,113 $ 194,188 $ (9,551) $ 5,543 $ 304,553
Balance at beginning of period (in shares) at Dec. 31, 2024 25,978,904          
Increase (Decrease) in Shareholder's Equity            
Net income     5,763     5,763
Other comprehensive loss / income         1,458 1,458
ESOP shares committed to be released   (23)   171   148
Stock-based compensation expense   351       351
Restricted stock awards granted (in shares) 5,000          
Repurchases of common stock $ (2)   (1,570)     (1,572)
Repurchases of common stock (in shares) (130,813)          
Balance at end of period at Mar. 31, 2025 $ 258 114,441 198,381 (9,380) 7,001 310,701
Balance at end of period (in shares) at Mar. 31, 2025 25,853,091          
Balance at beginning of period at Dec. 31, 2025 $ 251 115,400 203,045 (8,868) 14,033 $ 323,861
Balance at beginning of period (in shares) at Dec. 31, 2025 25,072,214         25,072,214
Increase (Decrease) in Shareholder's Equity            
Net income     5,290     $ 5,290
Other comprehensive loss / income         (1,152) (1,152)
ESOP shares committed to be released   9   170   179
Stock-based compensation expense   360       360
Stock options exercised   47       47
Stock options exercised (shares) 5,000          
Repurchases of common stock (in shares) (413)          
Balance at end of period at Mar. 31, 2026 $ 251 $ 115,816 $ 208,335 $ (8,698) $ 12,881 $ 328,585
Balance at end of period (in shares) at Mar. 31, 2026 25,076,801         25,076,801